LivaNova PLC
LIVN
Peringkat dalam Saham
#3842
LivaNova PLC is a global medical technology company dedicated to developing,... LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.
Harga Saham
$78.96
Kapitalisasi Pasar
$4.34B
Perubahan (1 hari)
-0.94%
Perubahan (1 tahun)
44.32%
Negara
GB
Perdagangan LivaNova PLC (LIVN)
Kategori
Healthcare
Jumlah saham beredar untuk LivaNova PLC (LIVN)
Jumlah saham beredar per June 2026: 55.00M
Menurut laporan keuangan terbaru dan harga saham LivaNova PLC, jumlah saham beredar saat ini adalah 55.00M. Pada akhir December 2023, perusahaan memiliki 53.90M saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk LivaNova PLC (LIVN) dari 2000 hingga 2026
Saham beredar pada akhir setiap tahun
| Tahun | Saham Beredar | Mengubah |
|---|---|---|
| 2026 (TTM) | 55.00M | 1.40% |
| 2024 | 54.24M | 0.63% |
| 2023 | 53.90M | 0.75% |
| 2022 | 53.50M | 5.66% |
| 2021 | 50.63M | 4.20% |
| 2020 | 48.59M | 0.50% |
| 2019 | 48.35M | -0.30% |
| 2018 | 48.50M | 0.61% |
| 2017 | 48.20M | -1.35% |
| 2016 | 48.86M | 85.14% |
| 2015 | 26.39M | -2.77% |
| 2014 | 27.14M | -1.67% |
| 2013 | 27.60M | -0.80% |
| 2012 | 27.83M | -0.80% |
| 2011 | 28.05M | 1.26% |
| 2010 | 27.70M | 4.02% |
| 2009 | 26.63M | 0.50% |
| 2008 | 26.50M | 3.86% |
| 2007 | 25.51M | 2.40% |
| 2006 | 24.92M | 3.66% |
| 2005 | 24.04M | 4.10% |
| 2004 | 23.09M | 4.79% |
| 2003 | 22.03M | 1.75% |
| 2002 | 21.66M | 20.01% |
| 2000 | 18.04M | 0.00% |
Saham beredar untuk perusahaan serupa atau pesaing
| Perusahaan | Saham Beredar | Perbedaan | Negara |
|---|---|---|---|
| 1.74B | 3,069.18% |
US
|
|
| 1.28B | 2,231.09% |
IE
|
|
| 383.50M | 597.27% |
US
|
|
| 1.48B | 2,586.55% |
US
|
|
| - | - |
DE
|
